CoChat

Understanding China's shifting priorities and priority-setting processes in development assistance for health

Open access
Guo, Bingqing, Fan, Victoria, Strange, Austin, Grépin, Karen Ann · 2024 · Health Policy and Planning

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Over the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of Chinese DAH and compare them to comparable trends among OECD Development Assistance Committee (DAC) donors using data from the AidData’s Global Chinese Development Finance Dataset (2000–2017, version 2.0) and the Creditor Reporting System (CRS) database (2000–2017). We also analyse Chinese medical aid exports before and after the start of the COVID-19 pandemic using a Chinese Aid Exports Database. We further explore the potential factors influencing China’s shifting priority-setting processes by reviewing Chinese official documents following Walt and Gilson’s policy analysis framework (context–actors–process–content) and by testing our conjectures empirically. We find that China has become an important DAH donor to most regions if measured using project value, including but not limited to Africa. China has prioritized aid to African and Asian countries as well as to CRS subsectors that are not prioritized by DAC donors, such as medical services and basic health infrastructure. Chinese quarterly medical aid exports almost quintupled after the start of the COVID-19 pandemic. Noticeably, China has allocated more attention to Asia, eye diseases and infectious disease outbreaks over time. In contrast, the priority given to malaria has declined over the same period. Regarding factors affecting priority shifts, the outbreaks of SARS and Ebola, the launch of the Belt and Road Initiative and the COVID-19 pandemic appear to be important milestones in the timeline of Chinese DAH. Unlike stereotypes of China as a ‘lone wolf’ donor, our analysis suggests multilateral processes are influential in informing and setting Chinese DAH priorities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/heapol/czad095

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. HP project count, value, and HP projects as a share of all Chinese development assistance projects from 2000 to 2017. Data source: AidData 2.0.
Figure 1. HP project count, value, and HP projects as a share of all Chinese development assistance projects from 2000 to 2017. Data source: AidData 2.0.CC BY-NC · PubMed Central
Figure 2. Top 10 bilateral donors of HP commitments in each region from (a) 2000 to 2003; (b) 2004 to 2013; (c) 2014 to 2017. Ranked from bottom to top by the HP project value (median imputation). Datasource: AidData 2.0 and CRS datasets.
Figure 2. Top 10 bilateral donors of HP commitments in each region from (a) 2000 to 2003; (b) 2004 to 2013; (c) 2014 to 2017. Ranked from bottom to top by the HP project value (median imputation). Datasource: AidData 2.0 and CRS datasets.CC BY-NC · PubMed Central
Figure 3. Top 10 bilateral donors of HP commitments in each region from (a) 2000 to 2003; (b) 2004 to 2013; (c) 2014 to 2017. Ranked from the bottom to the top by the HP project count. Data source: AidData 2.0 and CRS datasets.
Figure 3. Top 10 bilateral donors of HP commitments in each region from (a) 2000 to 2003; (b) 2004 to 2013; (c) 2014 to 2017. Ranked from the bottom to the top by the HP project count. Data source: AidData 2.0 and CRS datasets.CC BY-NC · PubMed Central
Figure 4. Distribution of HP commitments across regions ((a) China and (b) DAC donors) and CRS subsectors ((c) China and (d) DAC donors) by year from 2000 to 2017, measured by the HP project value (median imputation). Data source: AidData 2.0 and CRS datasets.
Figure 4. Distribution of HP commitments across regions ((a) China and (b) DAC donors) and CRS subsectors ((c) China and (d) DAC donors) by year from 2000 to 2017, measured by the HP project value (median imputation). Data source: AidData 2.0 and CRS datasets.CC BY-NC · PubMed Central
Figure 5. Distribution of HP commitments across regions ((a) China and (b) DAC) and CRS subsectors ((c) China and (d) DAC) by year from 2000 to 2017, measured by the HP project count. Data source: AidData 2.0 and CRS datasets.
Figure 5. Distribution of HP commitments across regions ((a) China and (b) DAC) and CRS subsectors ((c) China and (d) DAC) by year from 2000 to 2017, measured by the HP project count. Data source: AidData 2.0 and CRS datasets.CC BY-NC · PubMed Central
Figure 6. Chinese HP projects by specific health issue and by year from 2000 to 2017, measured by (a) Project count and (b) Project value (median imputation). NCDs= non-communicable diseases. Data source: AidData 2.0.
Figure 6. Chinese HP projects by specific health issue and by year from 2000 to 2017, measured by (a) Project count and (b) Project value (median imputation). NCDs= non-communicable diseases. Data source: AidData 2.0.CC BY-NC · PubMed Central
Figure 7. Chinese HP projects by specific communicable disease, by year (2000 to 2017), measured by (a) Project count and (b) Project value (median imputation). Two reference lines correspond to the outbreak of SARS in China and Ebola in West Africa. The line graphs illustrated new malaria cases number in China overtime. Data sources: AidData 2.0 and surveillance reports on China’s notifiable infectious diseases of National Health Commission of China (2003-2017).
Figure 7. Chinese HP projects by specific communicable disease, by year (2000 to 2017), measured by (a) Project count and (b) Project value (median imputation). Two reference lines correspond to the outbreak of SARS in China and Ebola in West Africa. The line graphs illustrated new malaria cases number in China overtime. Data sources: AidData 2.0 and surveillance reports on China’s notifiable infectious diseases of National Health Commission of China (2003-2017).CC BY-NC · PubMed Central
Figure 8. Chinese aid exports by quarter from January 2017 to September 2022. The reference line divides the period into pre- COVID-19 and post- COVID-19. Data source: Chinese Aid Exports Database.
Figure 8. Chinese aid exports by quarter from January 2017 to September 2022. The reference line divides the period into pre- COVID-19 and post- COVID-19. Data source: Chinese Aid Exports Database.CC BY-NC · PubMed Central
Figure 9. Distribution of Chinese medical aid exports across regions by quarter from January 2017 to September 2022, measured by the amount in current US$. The reference line divides the period into pre- COVID-19 and post- COVID-19. Data source: Chinese Aid Exports Database.
Figure 9. Distribution of Chinese medical aid exports across regions by quarter from January 2017 to September 2022, measured by the amount in current US$. The reference line divides the period into pre- COVID-19 and post- COVID-19. Data source: Chinese Aid Exports Database.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 3

  1. Custer, 2021, Tracking Chinese Development Finance: An Application of AidData’s TUFF 2.0 Methodology
  2. Luo, 2011, Discussion on the effects and challenges of ‘Global Health Diplomacy’ on China, The Journal of International Studies, 2, 45
  3. Xian, 2017, Analysis on the evolution and trend of malaria prevention and control policies in China, Chinese Journal of Health Policy, 10, 70

Cited by

See all 8

Metadata

Authors
Guo, B., Fan, V., Strange, A., & Grépin, K. A.
Affiliations
  • University of Hong Kong (HK)
  • Center for Global Development (US)
Corresponding author
Grépin, Karen Ann
Venue
Health Policy and Planning
Published
2024-01-01
Volume
39
Issue
Supplement_1
Pages
i65-i78
ISSN
  • 0268-1080 (ISSN-L)
  • 1460-2237
OpenAlex
W4391116185
Cited by
8
References
34
Citations by year
2026: 1 · 2025: 4 · 2024: 2
FWCI
7.19
Type
journal article
Language
en
Open access
Locations
  • Health Policy and Planning (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
  • Research Explorer (The University of Manchester) (submittedVersion)
Topics
  • Social Sciences › Development › International Development and Aid
  • Social Sciences › Political Science and International Relations › Public health and occupational medicine
  • Social Sciences › Arts and Humanities › History › Historical and Contemporary Political Dynamics
Keywords
COVID-19 pandemic, Belt and Road Initiative, SARS, Ebola, malaria, infectious disease outbreaks, eye diseases, health infrastructure, China-Africa relations
MeSH terms
COVID-19, Africa, Asia, China, Humans, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Understanding China's shifting priorities and priority-setting processes in development assistance for health. https://app.cochat.ai/papers/10.1093/heapol/czad095
The paper
Guo, B., Fan, V., Strange, A., & Grépin, K. A. (2024). Understanding China's shifting priorities and priority-setting processes in development assistance for health. Health Policy and Planning. https://doi.org/10.1093/heapol/czad095

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.